HR
TEVA icon

Howe & Rusling’s Teva Pharmaceuticals TEVA Stock Holding History

Howe & Rusling’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$1K – 957
2022
Q3 		$1K Buy
+100
New +$884 ﹤0.01% 1012
2018
Q4 		– Sell
-704
Closed -$15K – 893
2018
Q3 		$15K Buy
+704
New +$16.3K ﹤0.01% 438
2018
Q1 		– Sell
-55
Closed -$1K – 999
2017
Q4 		$1K Sell
55
-2,042
-97% -$30.7K ﹤0.01% 803
2017
Q3 		$37K Sell
2,097
-501
-19% -$11.3K 0.01% 330
2017
Q2 		$86K Hold
2,598
– – 0.02% 218
2017
Q1 		$83K Buy
2,598
+1,937
+293% +$66.1K 0.02% 215
2016
Q4 		$24K Sell
661
-2,396
-78% -$95.7K 0.01% 339
2016
Q3 		$141K Buy
3,057
+129
+4% +$6.73K 0.03% 166
2016
Q2 		$147K Sell
2,928
-300
-9% -$16K 0.03% 154
2016
Q1 		$173K Buy
3,228
+565
+21% +$33.2K 0.04% 150
2015
Q4 		$175K Sell
2,663
-187
-7% -$11.6K 0.04% 155
2015
Q3 		$161K Sell
2,850
-432
-13% -$28K 0.04% 167
2015
Q2 		$194K Hold
3,282
– – 0.04% 163
2015
Q1 		$204K Buy
3,282
+267
+9% +$15.5K 0.05% 156
2014
Q4 		$173K Hold
3,015
– – 0.04% 156
2014
Q3 		$162K Sell
3,015
-63
-2% -$3.34K 0.04% 154
2014
Q2 		$161K Buy
3,078
+105
+4% +$5.37K 0.04% 166
2014
Q1 		$157K Buy
2,973
+910
+44% +$42.1K 0.04% 164
2013
Q4 		$83K Sell
2,063
-1,071
-34% -$42.2K 0.02% 230
2013
Q3 		$119K Buy
3,134
+188
+6% +$7.33K 0.04% 182
2013
Q2 		$115K Buy
+2,946
New +$115K 0.03% 206

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Howe & Rusling's TEVA Position: Q4 2022 in Review

Howe & Rusling sold out of Teva Pharmaceuticals (TEVA) in Q4 2022, closing a stake of 100 shares — an estimated $1K sold.

Howe & Rusling first reported a position in TEVA in Q2 2013 and held it in 21 quarters. The position peaked at $204K in Q1 2015. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Howe & Rusling reported no remaining Teva Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 100 Teva Pharmaceuticals shares in Q4 2022, an estimated $1K.
  • Howe & Rusling first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 21 quarters.
  • Howe & Rusling's Teva Pharmaceuticals position peaked at $204K in Q1 2015.
  • 422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.